Aims: Some low-grade malignant tumours arising in the abdomen tend to remain loco-regionally confined to peritoneal surfaces, without systemic dissemination. In these cases complete surgical tumour cytoreduction followed by intra-or post-operative regional chemotherapy has curative potential. The aim of this study was to evaluate the outcome for patients treated in this way. Methods: Peritonectomy was performed, involving the complete removal of all the visceral and parietal peritoneum involved by disease. After peritonectomy, hyperthermic antiblastic perfusion was carried out throughout the abdominopelvic cavity for 90 min, at a temperature of 41.5-42.5°C, with mitomycin C (3.3 mg/m 2 /l) and cisplatin (25 mg/m 2 /l) (for appendicular or colorectal primaries), or cisplatin alone (for ovarian primaries). Alternatively, the immediate post-operative regional chemotherapy was performed with 5-fluorouracil (13.5 mg/kg) and Lederfolin (125 mg/m 2 ) (for colonic or appendicular tumours) or cisplatin (25 mg/m 2 ) (for ovarian tumours), each day for 5 days. Results: Thirty-five patients affected by extensive peritoneal carcinomatosis were submitted to peritonectomy, with no residual macroscopic disease in all cases except three. Twenty-six patients were able to undergo the combined treatment involving loco-regional chemotherapy. Complications were observed in 54% of the patients and led to death in four of them. At a mean follow-up of 17 months overall 2-year survival was 55.2%, with a median survival of 26 months. Conclusions: After a learning curve of 18 months the feasibility of the integrated treatment increased to more than 90%, while mortality decreased dramatically. The curative potential of the combined therapeutic approach seems high in selected patients with peritoneal carcinomatosis not responding to systemic chemotherapy. Careful selection of patients can minimize the surgical risk, but the treatment should currently be reserved for clinical trials.
Introduction
patients after repeated regional treatment. This suggested that the peritoneum could be the 'last margin' in selected Peritoneal carcinomatosis can originate from transparietal cases and the intent of surgery should therefore be not spread of low-grade malignant tumours. In these cases, the simply to perform a debulking operation but to obtain peritoneal involvement is not a consequence of intrinsic complete tumour cytoreduction by peritonectomy. biological aggressiveness, but due to the effects of gravity, After cytoreduction, intraoperative hyperthermic intestinal peristaltic movements and peritoneal perfusion or immediate post-operative abdomino-pelvic reabsorption. Sugarbaker has named this pathway antiblastic infusion provide direct contact between drugs neoplastic 'redistribution'. 1 and residual free neoplastic cells when they are exposed and Traditional surgery has always had palliation as its only vulnerable. objective, 2 the peritoneal carcinomatosis being considered Peritonectomy has been proposed and codified in terms as a systemic disease. However, in 1968 Long et al. 3 reported of rationale and surgical technique by Sugarbaker. 4 In his long survival times in low-grade peritoneal carcinomatosis experience of 181 consecutive patients with peritoneal carcinomatosis, the association of peritonectomy and adjuvant chemotherapy resulted in an actuarial survival rate Based on this rationale, we employed the combination of abdomen through the drains into the reservoir occurs by gravity. Thermocouples are positioned at inflow and outflow peritonectomy and regional chemotherapy in patients with advanced peritoneal carcinomatosis from low-grade sites, in the sub-diaphragmatic spaces, on the mesentery, in the pelvis and as close as possible to any residual neoplastic malignant tumours. The present paper reports our experience in 35 consecutive patients.
nodules which could not be removed, and the temperatures are monitored. The perfusate is heated to 44-45°C in order to reach a temperature of 41.5-42.5°C throughout the abdominoMethods pelvic cavity, which according to our studies 8 corresponds to the optimal temperature to obtain effective synergism Peritonectomy with the employed antineoplastic drugs, whilst limiting Total peritonectomy involves several surgical procedures, regional toxicity to acceptable levels. At this abdominal based on division of the peritoneum into different surgical temperature, mitomycin C (3.3 mg/m 2 /l) and cisplatin areas. The dissection should remain extraperitoneal until (25 mg/m 2 /l) are introduced into the perfusion circuit for most of the sub-diaphragmatic and parietocolic peritoneum carcinomatosis originating from appendicular or colorectal is exposed. The peritoneum is then opened and the abdomen tumours; cisplatin alone is utilized for primary ovarian is carefully explored. Peritoneal washing is carried out and tumours. Hyperthermic antiblastic perfusion is undertaken the fluid is analysed by both conventional cytology and for 90 min, after which the abdomen is washed and immunocytology to detect the presence of neoplastic cells. 6, 7 immunocytology is again employed to search for neoplastic The results constitute a reference point, when the same cells in the washing solution. Visceral anastomoses are then analysis is repeated at the end of surgery and after regional carried out and thoracic tubes are inserted in the right and chemotherapy. The surgical technique has been described left pleural cavities to evacuate fluid accumulating in the in detail by Sugarbaker 4 and can be summarized as follows: chest as a result of both electro-surgery on the subdiaphragmatic peritoneum and the abdominal hyperthermic (1) Peritoneal stripping from the cephalic portion of the right hemiabdominal wall and right sub-diaphragm, antiblastic perfusion. Finally, the abdomen is closed in routine fashion. together with peritonectomy of Morrison's pouch. when intraoperative deterioration of the patient's general (4) Omentectomy in continuity with the superficial layer of condition limits operative time and therefore HAP cannot the transverse mesocolon and the anterior surface of be carried out. In this case, before closing the abdomen, the pancreas, followed by splenectomy.
two inflow catheters are placed in the left upper quadrant (5) Peritoneal stripping from the right and left caudal as close as possible to the ligament of Treitz and in the portions of the abdominal wall, from the bladder and right sub-diaphragmatic space. Drains are positioned in the iliac fossa preserving the ureters; resection of the sigmoid right parietocolic space and in the pelvis. One hour after colon and mesosigmoid from the origin of inferior the operation 1 l of 1.5% dextrose peritoneal dialysis solution mesenteric artery.
at 37°C is infused through the inflow catheters as rapidly (6) Pelvic peritonectomy, dividing the subperitoneal rectum as possible. The outflow drains are closed during infusion and vagina in women to remove en bloc all the neoplastic and reopened after a short dwell time. This abdominal tissue in the peritoneal cul de sac; closure of the vagina lavage is repeated every 6 h. The aim of this procedure is and colorectal anastomosis, after mobilization of the to prevent early adhesions and to cleanse the abdominal entire left colon.
cavity. (7) The operation is completed by removing all traces of Approximately 24 h post-operatively, chemotherapy is visceral disease, most frequently leading to right begun. The drains are closed and 1 l of 1.5% dextrose colectomy, the caecum and the right parietocolic peritoneal dialysis solution is infused at body temperature, peritoneum. Resection of the gastric antrum due to the containing 5-fluorouracil (13.5 mg/kg) and Lederfolin presence of tumour deposits may also be necessary.
(125 mg/m 2 ) for a primary colonic or appendicular tumour or cisplatin (25 mg/m 2 ) for a primary ovarian tumour. The drains remain closed for 23 h and are then reopened for 1 h Hyperthermic antiblastic perfusion (HAP) until the next infusion is performed. The same procedure is Prior to performing intestinal anastomoses, the repeated every 24 h for 5 days, using the same drug doses. peritonectomy procedure is completed by carrying out Drainage fluid is examined for neoplastic cells using hyperthermic antiblastic perfusion throughout the abdomen conventional cytology and immunocytology. by positioning two inflow catheters under the diaphragm and two large outflow drains in the pelvis. The
Patients and results extracorporeal circuit pump, equipped with heat exchanger and reservoir filter, pumps the heated perfusion isotonic Between April 1995 and December 1998, 35 patients with peritoneal carcinomatosis (27 female, eight male) were fluid into the abdominal cavity, while the outflow from the (Tables   failure  disease   1 and 2). The carcinomatosis was extensive in all cases, with a Sugarbaker peritoneal cancer index (PCI) 9 of 16. Preoperatively, five patients had symptoms of intestinal Hyperthermic antiblastic perfusion was performed in 21 carcinomatosis patients (11 from ovarian cystoadenoobstruction and one had previously undergone an ileotransversostomy elsewhere for this reason. Seven patients carcinoma, five from colorectal adenocarcinoma, two from malignant mesothelioma and two from adenocarcinoma had ascites. Pre-operatively all the patients were staged by spiral abdominopelvic CT scan, and when indicated with of the appendix), while immediate post-operative intraabdominal chemotherapy was administered in five patients peritoneography, to exclude the presence of untreatable mesenteric disease. CT peritoneography was performed after (four from colonic adenocarcinoma and one from ovarian cysto-adenocarcinoma). When loco-regional chemotherapy infusion of 2 l of isotonic solution and contrast medium into the abdominal cavity, and was highly effective in could not be given, systemic chemotherapy was administered. Major post-operative complications occurred in 13 detecting small implants on the serosal surfaces. It allows detection of disease on the mesentery which, if extensive, patients, requiring reoperation in six and leading to death in two (Table 4 ). The duration of the surgical procedure represents a contraindication to peritonectomy.
Total peritonectomy was performed in 20 patients, while was directly correlated with the clinical outcome (P=0.03) (Fig. 1) . subtotal peritonectomy was carried out in 15 because of less widespread carcinomatosis (or developing complications).
Malignant cells were present in the peritoneal washing in 70% of patients at the time of peritonectomy and remained At the end of the learning curve, the average duration of the surgical procedure was 10 h (range 6 to 15 h), excluding positive soon after the loco-regional chemotherapy in 36%, but no correlation with survival was recorded. The delayed the HAP time. Intraoperative complications occurred in six patients, and in three forced peritonectomy to be abandoned analysis of drainage fluid was positive in only two patients, who both had early recurrence. before the cytoreduction was completed (Table 3) . liquid to the reabsorption sites, establish contact with the peritoneum. In summary, three factors are characteristically involved in the abdominal spread of low-grade or mucinous cancer: peristalsis, gravity and reabsorption. 1,11-14 These, together with the biological aggressiveness of the tumour, lead to a wide range of 'random redistribution'.
Conversely, the less differentiated aggressive tumours that are not producing mucin, when overcoming the intestinal wall release emboli that are distributed in a disorderly fashion, but always starting close to the primary tumour, since the adhesion molecules cause neoplastic cells to implant on the first structure encountered, regardless of any other mechanism. In our series, all patients showed widespread and often symptomatic carcinomatosis, with a Sugarbaker peritoneal cancer index of 16, but small bowel implants were rare, On the basis of these considerations, a two-stage treatment with curative intent becomes feasible: complete cytoreductive surgery, where the peritoneum represents the Table 5 . Survival related to primary tumour 'last margin', and loco-regional hyperthermic chemotherapy intraoperatively or immediately post-operative.
years Median Longest
Complete cytoreduction is mandatory because intrasurvival (%) survival disease-free (months) survival abdominal chemotherapy is unlikely to be curative if (months) neoplastic aggregates are larger than a few millimetres. 9 No statistical difference in survival using intra-or post-operative In the early part of our experience, we did not perform several HAPs because of the longer operative time due to the technical learning curve, delaying the loco-regional After discharge, all patients were frequently reviewed and none were lost to follow-up. At a median follow-up of 17 chemotherapy to the first operative day, but EPIC administration was often jeopardized by the post-operative months the overall 2-year survival was 55.2% with a median survival of 26 months. Survival breakdown is summarized general conditions of the patients. After this early experience, significant decreases in operative time and in in Table 5 .
intraoperative blood loss allowed us to switch to HAP and in the following 18 months we achieved a combined treatment feasibility of more than 90%.
Discussion
Some major problems influenced the surgical performance, for the most part in the early part of our Peritoneal carcinomatosis frequently presents as extensive regional disease, without haematogenous metastases. 10 This experience. Firstly, peritoneal stripping from both the tendinous and the posterior aspects of the diaphragm, due Although no conclusions can be drawn, only 28% of the patients that could not be treated by loco-regional to difficult access and the muscular contractions stimulated by electrosurgery, sometimes led to penetration of the pleural chemotherapy and who were submitted to systemic chemotherapy are alive at a median follow-up of 17 months cavity. As a result neoplastic cells were found in one patient on routine immunocytological examination of drained vs 79% of the patients who completed the combined treatment (P=NS). pleural fluid.
Subsequently, the frequency of diaphragmatic penetration In conclusion, the curative potential of this combined therapeutic approach is high in patients with peritoneal was reduced with deeper anaesthesia, and finally avoided completely by employing an ultrasound knife (Ultracisioncarcinomatosis not responding to systemic chemotherapy. Peritonectomy is supported by a convincing rationale and Ethicon Endosurgery, Cincinnati, OH, USA) to dissect the diaphragmatic peritoneum. This technique is somewhat the intra-abdominal antineoplastic drug administration, intra-or immediately post-operatively, has been slower, but appears to be safe and reliable, avoiding diaphragmatic penetration without significant bleeding.
demonstrated to optimize the loco-regional control of disease in an adjuvant setting. Another initial problem was excessive blood loss, which could have interfered with the completeness of
The procedure is still burdened by relatively high morbidity and mortality rates, even though the technical cytoreduction. It is mandatory, due to the long operative time, to proceed carefully, controlling any bleeding step by learning curve has led to shorter surgical times and no mortality has been recorded in the last 2 years. Strict patient step. Particular attention must be paid to bleeding caused by the stripping of Glisson's capsule both in the presence selection criteria can reduce the surgical risk and improve the post-operative outcome. At present, however, such of a few neoplastic implants on the liver surface or of bulky disease not penetrating the liver parenchyma. In the former combined treatment should be confined to clinical trials. situation, the procedure of choice is a smooth dissection; in the latter the only possibility is electrosurgical destruction, Acknowledgments layer by layer, of the neoplastic mass.
The complication rate remains high, approximately 50%, This study was supported by Ministero della Sanità ICS but it has to be pointed out that almost all the patients 120.1,1/RF97/75. Acknowledgments are due to all staff of included in this series had been previously treated by surgery the Operating Theatre, Intensive Care Unit and Ward who and several regimens of systemic chemotherapy.
were involved in the care of the patients in this study. The We did not find any correlation between loco-regional authors wish to thank Miss Giuseppina Gioffrè for her chemotherapy and complication rate, neither overall, nor excellent support in data management and preparation of considering anastomotic dehiscences alone; on univariate the manuscript. analysis, the duration of the surgical procedure seemed to be directly correlated to the clinical outcome.
The mortality rate progressively decreased to the present References level of 11%, with no new event recorded from December 1996. tumour where the 2-year disease-free survival is absolute.
COMMENTARY
Commentary regarding: F. Cavaliere et al.-Peritonectomy and I agree with these authors regarding the cause of the 54% morbidity. It results from the demanding, even heroic, surgery that hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
the management of peritoneal surface malignancy requires. No evidence to suggest that hyperthermic perfusion added to the complication rate is presented here or in other publications. It is a great pleasure for me to review the initial work of this highly There is one lesson in cytoreduction I learned the hard way, and respected group of cancer surgeons with the treatment of peritoneal this group is also learning from experience. When the patient and surface malignancy. They accepted for treatment 35 patients, and the surgical oncologist are pushed to the limit, a diverting ostomy 32 had a complete resection to no visible evidence of cancer. Twentymay be 'the better part of surgical valour'. The judicious use of six had heated peritoneal perfusion in the operating room, while the time-honoured diverting and decompressing ileostomy may nine had five consecutive days of intraperitoneal chemotherapy in have reduced the morbidity to less than half by eliminating fistula, the early post-operative period. None of these patients had both anastomotic leak, intestinal necrosis and prolonged ileus. Closure heated intraoperative and early post-operative intraperitoneal with a second look at 6-9 months is routine in about one-third of chemotherapy as is routinely used at the Washington Cancer our patients. Institute. Of special mention is a treatment-related mortality of I disagree with these authors regarding the need for further 11% and a morbidity of 54%.
clinical trials. These management strategies work, but the learning In order to place this study in perspective one must first review curve of 18 months and 35 patients is insufficient to claim expertise. the patient selection utilized at Regina Elena National Cancer
To provide the greatest benefit at minimal cost to patients and Institute. Thirty-three of their 35 patients had aggressive and providers, referral centres that commit themselves over many years metastatically efficient cancer (18 ovarian, 11 colorectal and four to a high level of competency are mandatory. Knowledgeable peritoneal mesothelioma). Not only would these invasive cancers patient selection and a high level of surgical oncology skill will be difficult or impossible to adequately cytoreduce, but most will take many years of practice. develop systemic disease that will confound any prolongation of I congratulate this group on their early efforts in this important survival caused by loco-regional control. 
